+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system



PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system



Cancer Science 109(8): 2558-2566



PIK3CA mutations are common activating mutations associated with breast cancer (occurring in 20-30% of all cases) and are potent predictive markers for responses to PI3K inhibitors. Thus, it is important to develop sensitive methods to detect these mutations. We established a novel detection method using a quenching probe (QP) system to identify PIK3CA mutations, using DNA from 309 breast cancer tissues. In a developmental cohort, we determined the optimal detection threshold of the QP system with human tumor DNA from 119 freshly frozen tumor samples. We found a 96% concordance rate with the QP system between DNA from 26 matching fresh-frozen specimens and formalin-fixed paraffin-embedded (FFPE) specimens from the same patients, and known PIK3CA mutation status in the developmental cohort. In a validation cohort, we evaluated whether the threshold for judging mutations using the QP system with frozen specimen-derived DNA was applicable with FFPE-derived DNA. In the validation cohort, 30 DNA samples from 190 FFPE-derived DNA samples with known PIK3CA mutation status were analyzed by direct sequencing (DS) and droplet digital PCR, in a blinded manner. The sensitivity and specificity of the droplet digital PCR results were 100% and 100% (QP system), and 60% and 100% (DS), respectively. We also analyzed the relationship between clinical outcomes and the PIK3CA mutational status of 309 breast cancer samples, including the developmental cohort and validation cohort samples. Multivariate analysis suggested that PIK3CA mutations, especially H1047R, were prognostic factors of relapse-free survival. Our novel detection system could be more useful than DS for detecting clinical PIK3CA mutations.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065409189

Download citation: RISBibTeXText

PMID: 29906308

DOI: 10.1111/cas.13696


Related references

Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method. Bmc Cancer 16: 454, 2016

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proceedings Of The National Academy Of Sciences Of The United States Of America. 93(3): 1093-1096, 1996

Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway. Plos one 5(12): E15647, 2010

PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer. Plos one 8(1): E53292, 2013

A novel PIK3CA hotspot mutation in Isfahanian breast cancer patients. Cancer Investigation 29(4): 313-317, 2011

Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation. Journal of Thoracic Oncology 7(11): 1640-1644, 2012

PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients. Annals of Surgical Oncology 15(4): 1064-1069, 2008

Highly sensitive detection of the MGB1 transcript in the peripheral blood of breast cancer patients. EJC Suppl.s 1(5): S125, 2003

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups. Breast Cancer Research 14(1): R28, 2012

Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients. International Journal of Cancer 108(4): 592-595, 2003

Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR. Molecular Diagnosis and Therapy 21(4): 443-451, 2017

Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers. Analytical Chemistry 83(9): 3392-3397, 2011

Detection of a highly sensitive tumor associated isoform of mucin glycoprotein ca m26 in serum of patients with active breast cancer. Breast Cancer Research & Treatment 16(2): 164, 1990

Mutation profiling in the PIK3CA, TP53, and CDKN2A genes in circulating free DNA and impalpable breast lesions. Annals of Diagnostic Pathology 39: 30-35, 2019

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast Cancer Research and Treatment 120(2): 461-467, 2010